Improvement of trochanteric bone quality in an osteoporosis model after short-term treatment with parathyroid hormone: a new mechanical test for trochanteric region of rat femur

Osteoporos Int. 2010 Feb;21(2):251-61. doi: 10.1007/s00198-009-0941-y. Epub 2009 May 13.

Abstract

We have examined the changes induced in the trochanteric region of femur of ovariectomized rat after administration of estradiol and parathyroid hormone. We have developed a reproducible biomechanical test and produced trochanteric fractures to evaluate stiffness and strength of this region in addition to histomorphometry.

Introduction: We investigated the short-term effects of parathyroid hormone (PTH) and estrogen (E) on the strength of the rat trochanteric region in a new mechanical test.

Methods: Forty-four 3-month-old female Sprague-Dawley rats were ovariectomized and 8 weeks later treated with soy-free diet (C), daily applications of orally supplied E (0.5 mg/kg food) or subcutaneously injected PTH (0.014 mg/kg), for 5 weeks, and an additional untreated group was added as sham-operated. The femurs were examined for biomechanical and histomorphometric changes.

Results: Our new mechanical test was validated in a right-left comparison. The PTH treatment induced significantly superior biomechanical results (F (max) = 225.3 N, stiffness = 314.9 N/mm) compared to E (F (max) = 182.9 N, stiffness = 237.2 N/mm), C (F (max) = 166.03 N, stiffness = 235.56 N/mm), and sham (F (max) = 192.1 N, stiffness = 267.2 N/mm). Animals of the PTH group demonstrated a significantly improved trabecular bone structure and area (75.67%) in comparison to the E (61.04%) and C (57.18%) groups.

Conclusion: Our new biomechanical test is valid and produces trochanteric fracture. Our results show that the short-term antiosteoporotic effects of PTH are in the trochanteric region of ovariectomized rat superior to E.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Animals
  • Bone Density Conservation Agents / therapeutic use*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical / methods
  • Elasticity
  • Estradiol / therapeutic use
  • Female
  • Femur / drug effects*
  • Femur / pathology
  • Femur / physiopathology
  • Hip Fractures / diagnostic imaging
  • Hip Fractures / etiology
  • Hip Fractures / physiopathology
  • Hip Fractures / prevention & control
  • Osteocalcin / blood
  • Osteoporosis / drug therapy*
  • Osteoporosis / physiopathology
  • Osteoporotic Fractures / diagnostic imaging
  • Osteoporotic Fractures / etiology
  • Osteoporotic Fractures / physiopathology
  • Osteoporotic Fractures / prevention & control
  • Ovariectomy
  • Parathyroid Hormone / therapeutic use*
  • Radiography
  • Rats
  • Rats, Sprague-Dawley
  • Stress, Mechanical

Substances

  • Bone Density Conservation Agents
  • Parathyroid Hormone
  • Osteocalcin
  • Estradiol